MPAM
Monarch Partners Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.16M | Buy |
62,327
+2,743
| +5% | +$183K | 1.23% | 18 |
|
|
2022
Q3 | $5.13M | Buy |
59,584
+13,016
| +28% | +$1.12M | 1.54% | 5 |
|
|
2022
Q2 | $4.16M | Buy |
+46,568
| New | +$4.16M | 1.16% | 12 |
|
|
2016
Q4 | – | Sell |
-34,280
| Closed | -$3.5M | – | 190 |
|
|
2016
Q3 | $3.5M | Buy |
+34,280
| New | +$3.5M | 0.33% | 97 |
|